Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Safilo Group S.p.A. (SFL.MI)
Padua, PD, IT
Safilo Group S.p.A. is actively involved in the design, manufacture, and both wholesale and retail dissemination of eyewear products. Its operations span North America, Europe, the Asia Pacific region, and numerous other international markets. The company's product line encompasses a variety of items such as optical frames, sunglasses, sports goggles, and helmets, including prescription frames. These are offered through a diverse brand portfolio featuring both proprietary and licensed names. Its own brand collection includes Carrera, Polaroid, Safilo, Smith, Blenders Eyewear, Privé Revaux, Adensco, Chesterfield, Elasta, and Emozioni. Furthermore, Safilo distributes products under licensed brands such as Banana Republic, BOSS, Carolina Herrera, Chiara Ferragni, David Beckham, Dsquared2, Fossil, havaianas, HUGO, Isabel Marant, Jimmy Choo, Juicy Couture, Kate Spade, LEVI'S, Liz Claiborne, Marc Jacobs, Missoni, M Missoni, Moschino and Love Moschino, Pierre Cardin, PORTS, rag&bone, Rebecca Minkoff, Tommy Hilfiger, Tommy Jeans, and Under Armour. The company supplies its offerings to a wide array of customers and points of sale, including opticians, optometrists, ophthalmologists, major distribution chains, department stores, specialized retailers, stores owned by its licensors, duty-free outlets, and sports shops. Sales are conducted via an extensive network of independent distributor partners. Formerly known as Safilo Holding S.p.A., the company rebranded to Safilo Group S.p.A. in September 2005. Established in 1878, Safilo Group S.p.A. maintains its corporate headquarters in Padua, Italy.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.89% | -3.23% | -13.44% | -23.25% | -16.24% | -20.10% | +73.11% | +14.39% | +14.22% | -61.43% | -96.26% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Instruments & Supplies: +7.9%-1.0% Q4'25: -6.1% (vs Q4'23)
-
EPS growth Medical - Instruments & Supplies: +16.3%+123.1% ★ Q4'25: +140.9% (vs Q4'23)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+6.4% Q4'25: +9.8% (vs Q4'23)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+6.5% Q4'25: -0.3% (vs Q4'23)
-
ROIC Medical - Instruments & Supplies: +6.0%+10.3% ★ Q4'25: -0.6% (vs Q4'23)
-
Share dilution Medical - Instruments & Supplies: +0.1%+2.2% Q4'25: +14.8% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×1.53× Q4'25: -20.24× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 5 EPS Ana. |
Dec 2027 6 Rev. Ana. 5 EPS Ana. |
Dec 2028 4 Rev. Ana. 3 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.28B
est: 1.28B (0.0%)
|
1.25B
est: 1.25B (+0.3%)
|
1.05B
est: 1.05B (-0.4%)
|
910.74M
est: 962.40M (-5.4%)
|
939.04M
est: 935.00M (+0.4%)
|
780.30M
est: 781.81M (-0.2%)
|
969.58M
est: 968.15M (+0.1%)
|
1.08B
est: 1.08B (0.0%)
|
1.02B
est: 1.01B (+1.8%)
|
993.22M
est: 993.47M (0.0%)
|
983.38M
est: 984.67M (-0.1%)
|
985.40M
968.28M – 994.92M
+0.1% YoY
|
1.02B
1.00B – 1.03B
+3.3% YoY
|
1.05B
1.05B – 1.05B
+3.4% YoY
|
1.06B
1.05B – 1.08B
+1.0% YoY
|
1.09B
1.07B – 1.10B
+2.2% YoY
|
| EBITDA |
30.27M
est: 91.56M (-66.9%)
|
-59.92M
est: 89.39M (-167.0%)
|
-164.75M
est: 75.26M (-318.9%)
|
11.45M
est: 68.90M (-83.4%)
|
-194.96M
est: 66.94M (-391.3%)
|
-16.27M
est: 55.97M (-129.1%)
|
109.37M
est: 69.31M (+57.8%)
|
129.10M
est: 77.10M (+67.5%)
|
56.35M
est: 89.40M (-37.0%)
|
90.49M
est: 88.23M (+2.6%)
|
64.19M
est: 87.45M (-26.6%)
|
87.52M
86.00M – 88.36M
+0.1% YoY
|
90.41M
88.91M – 91.67M
+3.3% YoY
|
93.53M
93.44M – 93.61M
+3.4% YoY
|
94.51M
92.90M – 95.63M
+1.0% YoY
|
96.59M
94.95M – 97.74M
+2.2% YoY
|
| EBIT |
-17.46M
est: 22.36M (-178.1%)
|
-115.05M
est: 21.83M (-627.1%)
|
-206.83M
est: 18.38M (-1,225.4%)
|
-25.08M
est: 16.82M (-249.1%)
|
-265.72M
est: 16.35M (-1,725.7%)
|
-75.65M
est: 13.67M (-653.5%)
|
56.16M
est: 16.92M (+231.8%)
|
80.71M
est: 18.83M (+328.7%)
|
1.13M
est: 50.25M (-97.8%)
|
50.03M
est: 49.60M (+0.9%)
|
64.19M
est: 49.16M (+30.6%)
|
49.20M
48.34M – 49.67M
+0.1% YoY
|
50.82M
49.98M – 51.53M
+3.3% YoY
|
52.57M
52.53M – 52.62M
+3.4% YoY
|
53.13M
52.22M – 53.75M
+1.0% YoY
|
54.30M
53.38M – 54.94M
+2.2% YoY
|
| Net Income |
-52.75M
est: 58.55M (-190.1%)
|
-142.10M
est: 91.57M (-255.2%)
|
-251.57M
est: -115.41M (-118.0%)
|
-32.45M
est: -162.53M (+80.0%)
|
-328.35M
est: -1.40M (-23,308.8%)
|
-72.97M
est: -85.87M (+15.0%)
|
21.28M
est: 9.65M (+120.5%)
|
54.16M
est: 33.10M (+63.6%)
|
-24.65M
est: 1.92M (-1,386.5%)
|
22.30M
est: 23.35M (-4.5%)
|
49.07M
est: 40.13M (+22.3%)
|
46.93M
40.06M – 53.70M
+17.0% YoY
|
55.32M
47.60M – 66.18M
+17.9% YoY
|
61.38M
53.75M – 77.07M
+11.0% YoY
|
70.05M
68.51M – 71.13M
+14.1% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
314.24M
est: 551.93M (-43.1%)
|
307.24M
est: 538.86M (-43.0%)
|
251.65M
est: 453.68M (-44.5%)
|
476.56M
est: 415.31M (+14.7%)
|
223.75M
est: 403.48M (-44.5%)
|
380.30M
est: 337.38M (+12.7%)
|
481.03M
est: 417.79M (+15.1%)
|
352.97M
est: 464.73M (-24.0%)
|
354.56M
est: 445.79M (-20.5%)
|
496.96M
est: 439.99M (+12.9%)
|
535.10M
est: 436.10M (+22.7%)
|
436.42M
428.84M – 440.63M
+0.1% YoY
|
450.86M
443.37M – 457.15M
+3.3% YoY
|
466.39M
465.97M – 466.81M
+3.4% YoY
|
471.28M
463.27M – 476.85M
+1.0% YoY
|
481.68M
473.50M – 487.39M
+2.2% YoY
|
| EPS |
-0.47
est: 0.14 (-432.3%)
|
-1.27
est: 0.22 (-674.2%)
|
-2.24
est: -0.28 (-703.6%)
|
-0.18
est: -0.39 (+54.1%)
|
-0.99
est: 0.00 (-29,120.8%)
|
-0.24
est: -0.21 (-15.7%)
|
0.07
est: 0.02 (+206.0%)
|
0.13
est: 0.08 (+62.5%)
|
-0.06
est: 0.00 (-1,387.3%)
|
0.05
est: 0.06 (-2.9%)
|
0.12
est: 0.09 (+31.1%)
|
0.11
0.09 – 0.13
+20.6% YoY
|
0.13
0.11 – 0.16
+19.6% YoY
|
0.15
0.13 – 0.18
+13.8% YoY
|
0.17
0.16 – 0.17
+10.2% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI EMU Small Cap UCITS ETF CES1.L | 0.06% | 669.2K | 0.58% |
| 2 | UBS MSCI EMU Small Cap UCITS ETF EUR dis UEFD.DE | 0.06% | 455.0K | 0.33% |
| 3 | Avantis International Small Cap Value ETF AVDV | 0.04% | 6.73M | 0.36% |
| 4 | Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF Dist MMS.PA | 0.04% | 250.8K | 0.40% |
| 5 | Avantis Global Small Cap Value UCITS ETF AVGS.L | 0.03% | 341.6K | 0.39% |
| 6 | iShares International Small-Cap Equity Factor ETF ISCF | 0.03% | 188.6K | 0.24% |
| 7 | Xtrackers MSCI Europe Small Cap UCITS ETF 1C XXSC.L | 0.02% | 766.8K | 0.30% |
| 8 | iShares MSCI Europe Small-Cap ETF IEUS | 0.02% | 39.2K | 0.41% |
| 9 | State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR Acc ZPRX.DE | 0.02% | 166.7K | 0.30% |
| 10 | Dimensional - International Small Cap Value ETF DISV | 0.02% | 899.5K | 0.42% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Angelo Trocchia | Chief Executive Officer & Director | 3M | male |
| Barbara Ferrante | Director of Investor Relations | — | female |
| Fabio Roppoli | Chief Product Supply Officer | — | male |
| Michele Melotti | Chief Financial Officer | — | male |
| Vladimiro Baldin | Chief Licensed Brand & Global Product Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SFL.MI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
